SCHEMBL6353229

SCHEMBL6353229

CCCCC(CC)CC1(CC(CC)CCCC)c2ccccc2-c2ccc(-c3ccc4c(c3)Cc3ccccc3-4)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 1/20 0.35
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5502936 0.86 MEN1 (0.38) MAPTMEN1KMT2AL3MBTL1CYP3A4
SCHEMBL29377775 0.82 L3MBTL1 (0.46) MAPTMEN1KMT2AL3MBTL1CYP3A4
SCHEMBL3721035 0.82 L3MBTL1 (0.46) MAPTMEN1KMT2AL3MBTL1CYP3A4
SCHEMBL5501660 0.81 MEN1 (0.34) MAPTMEN1KMT2AL3MBTL1
SCHEMBL5503898 0.79 MEN1 (0.35) MAPTMEN1KMT2AL3MBTL1PDK2
SCHEMBL9898232 0.79 MEN1 (0.39) MAPTMEN1KMT2AL3MBTL1CYP3A4
SCHEMBL13607204 0.77 MEN1 (0.37) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL2143446 0.76 MAPT (0.35) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL14305778 0.76 ALDH1A1 (0.38) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL5901727 0.75 PTPN11 (0.41) MAPTMEN1KMT2AL3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050040757-A1 Light-emitting organic oligomer compositions UNIVERSITY OF ROCHESTER (US) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050040757-A1 Light-emitting organic oligomer compositions FUS, RAB5IF, ORC3 MMP12 4699/4885MMP13 4700/4885NPC1 1986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.